Results 131 to 140 of about 7,001,427 (209)

Clinical analysis of drug treatment trends for coronary heart disease in China. [PDF]

Front Med (Lausanne)
Li X, Lou J, Li X, Li S, Gu J, Zhang D, Luo Z, Cao J, Xie J.   +8 more
europepmc   +1 more source

Explanatory Variables of Objectively Measured 24 h Movement Behaviors in Coronary Heart Disease Patients: A Systematic Review. [PDF]

Clin Cardiol
Peng X, Guo T, Wang X, Wan Y, Peng Y, Cheng T, Tang S, Tu H.   +7 more
europepmc   +1 more source

Comprehensive Risk Factor Profiles, Coronary Heart Disease, and Life Expectancy in Cancer Survivors. [PDF]

JACC Adv
Cai YW, Zeng CR, Wu MX, Zhang Y, Liu PM, Wang JF, Gao JW, Zhang HF, Chen YX.   +8 more
europepmc   +1 more source

Longitudinal Changes in Frailty and Major Adverse Cardiovascular Events in Patients With Coronary Heart Disease. [PDF]

J Am Heart Assoc
Ding Y, He D, He J, Wu J, Shen Z, Chen S, Zhou D, Yuan C, Zhu Y, Huang H.   +9 more
europepmc   +1 more source

Interpreting circulating microbiome-related metabolites in coronary heart disease. [PDF]

PLoS Med
Sun Z, Shi M, Zheng Y.
europepmc   +1 more source

Integrative multi-omics analysis of metabolite-protein interaction networks across different stages of coronary heart disease. [PDF]

Sci Rep
Tan X, Gao Y, Wang J, Wang X, Pan Y, Chen M, Gao M, Zhang M, Zhang C, Ding P.   +9 more
europepmc   +1 more source

Midlife BMI and A Body Shape Index in relation to mortality and coronary heart disease events in a nationwide cohort. [PDF]

Front Nutr
Shafran I, Krakauer NY, Krakauer JC, Cohen G, Gerber Y.   +4 more
europepmc   +1 more source

The weight of timing: childhood-to-adulthood body mass index trajectories and the reversibility of coronary heart disease risk. [PDF]

J Thorac Dis
Akbilgic O.
europepmc   +1 more source